| 產(chǎn)品描述： | Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used clinically to treat type 2 diabetes mellitus. |
| 靶點(diǎn)： |
GLP-1 receptor;GlucagonReceptor |
| 參考文獻(xiàn)： |
1. Wang Y,et al. Transformation of oligomers of lipidated peptide induced by change in pH.Mol Pharm. 2015 Feb 2;12(2):411-9. 2. Wang YG, et al. Liraglutide reduces oxidized LDL-induced oxidative stress and fatty degeneration in Raw 264.7 cells involving the AMPK/SREBP1 pathway.J Geriatr Cardiol. 2015 Jul;12(4):410-416. |
| 溶解性： |
H2O : 9.09 mg/mL (2.42 mM; ultrasonic and adjust pH to 3 with HCl) |
| 保存條件： |
-20℃ |
| 配置溶液濃度參考： |
|
1mg |
5mg |
10mg |
| 1 mM |
0.267 ml |
1.333 ml |
2.666 ml |
| 5 mM |
0.053 ml |
0.267 ml |
0.533 ml |
| 10 mM |
0.027 ml |
0.133 ml |
0.267 ml |
| 50 mM |
0.005 ml |
0.027 ml |
0.053 ml |
|
| 注意： |
部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶參考交流研究之用。 |
上海工商
危險(xiǎn)品化學(xué)品經(jīng)營許可證（不帶存儲）
營業(yè)執(zhí)照(三證合一)
北京